Essays on the Drug Discovery Innovation System

dc.contributor.advisor	Hart, David M
dc.contributor.author	Sarkissian, Alfred
dc.creator	Sarkissian, Alfred
dc.date.accessioned	2018-10-22T01:20:33Z
dc.date.available	2018-10-22T01:20:33Z
dc.date.issued	2017
dc.identifier.uri	https://hdl.handle.net/1920/11297
dc.description.abstract	Despite the increase in scientific, monetary, and human resources devoted to drug discovery R&D, the annual number of FDA-approved drugs has been almost unchanged for decades. This study seeks clues to the R&D productivity paradox by exploring the drivers and barriers to innovation in the pharmaceutical industry. The main focus is on the contribution of science and knowledge form external sources to innovation.
dc.format.extent	294 pages
dc.language.iso	en
dc.rights	Copyright 2017 Alfred Sarkissian
dc.subject	Public policy	en_US
dc.subject	Breakthrough Innovations	en_US
dc.subject	Drug Discovery Innovation	en_US
dc.subject	Eroom’s Law	en_US
dc.subject	Innovation System	en_US
dc.subject	Orange Book	en_US
dc.subject	Patent Analysis	en_US
dc.title	Essays on the Drug Discovery Innovation System
dc.type	Dissertation
thesis.degree.level	Ph.D.
thesis.degree.discipline	Public Policy
thesis.degree.grantor	George Mason University